In recent years, clinical service provider organizations have had to reinvent themselves to keep up with a continually growing and fast changing industry. COVID-19, decentralization, growth of biologics and adaptive trialshave all put pressure on the traditional outsourced supply chain. Forward-thinking pharma sponsors and clinical service providers are collaborating closely and exploring new ways to bring drugs and medical products to market.
To work more effectively and bring investigational products to trial faster, the need for outsourcing has seen a surge globally. This inevitably brings new challenges and complexities around label management with multiple parties involved..